MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example MedicationRequest: Adavosertib

English

Profile: MII PR MTB Therapieempfehlung Systemische Therapie version: 2027.0.0-ballot.1

status: Draft

intent: Option

medication: ADAVOSERTIB

subject: Kim Musterperson (no stated gender), DoB: 1956-03-14

authoredOn: 2023-03-28

reasonReference: Condition Bösartige Neubildung: Peritoneum, nicht näher bezeichnet